JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB172637

Anti-RAG1 antibody [EPRAGR1]

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal RAG1 antibody. Suitable for WB and reacts with Mouse samples. Cited in 8 publications.

View Alternative Names

V(D)J recombination-activating protein 1, RAG-1, Rag1

1 Images
Western blot - Anti-RAG1 antibody [EPRAGR1] (AB172637)
  • WB

Supplier Data

Western blot - Anti-RAG1 antibody [EPRAGR1] (AB172637)

All lanes:

Western blot - Anti-RAG1 antibody [EPRAGR1] (ab172637) at 1/1000 dilution

All lanes:

Mouse thymus lysate at 10 µg

Predicted band size: 119 kDa

false

  • Carrier free

    Anti-RAG1 antibody [EPRAGR1] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPRAGR1

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RAG1 also known as Recombination Activating Gene 1 is an enzyme that has a mass of approximately 120 kDa. It functions mechanically by initiating the V(D)J recombination process that is essential for the development of immunoglobulin and T-cell receptor gene rearrangement. RAG1 achieves this by introducing double-stranded breaks in DNA guiding the recombination events. This protein is mainly expressed in developing lymphocytes within the bone marrow and thymus playing a significant function in the adaptive immune response.
Biological function summary

The recombination process performed by RAG1 is integral to generating the diversity of antibodies and T-cell receptors which form the foundation of the adaptive immune system. RAG1 acts as part of a protein complex with RAG2 where it collaborates to recognize and bind to recombination signal sequences in the DNA. This complex facilitates the accurate cleavage necessary for recombination enabling lymphocytes to produce a wide variety of receptors capable of recognizing numerous antigens.

Pathways

RAG1 directly participates in the antigen receptor rearrangement pathway which is fundamental to the adaptive immune system. It is closely linked to the DNA repair mechanisms required for joining the broken DNA ends it creates. Key proteins involved in these pathways include RAG2 which forms a complex with RAG1 and the DNA-dependent protein kinase which mediates the repair of DNA double-strand breaks ensuring genomic stability during immune cell development.

Improper function or mutations in RAG1 can result in severe combined immunodeficiency (SCID) or Omenn syndrome both of which severely impair the immune system. RAG1 mutations affect the recombination efficiency leading to decreased production of functional lymphocytes. The disorder connections extend to RAG2 as they together form the active RAG complex and defects in either can disrupt immune function highlighting the critical nature of these proteins in maintaining immune system efficacy.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps : a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends : 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In addition to its endonuclease activity, RAG1 also acts as an E3 ubiquitin-protein ligase that mediates monoubiquitination of histone H3. Histone H3 monoubiquitination is required for the joining step of V(D)J recombination. Mediates polyubiquitination of KPNA1.
See full target information Rag1

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:2194 PubMed38467629

2024

The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Xu,Taku Ito-Kureha,Hyun-Seo Kang,Aleksandar Chernev,Timsse Raj,Kai P Hoefig,Christine Hohn,Florian Giesert,Yinhu Wang,Wenliang Pan,Natalia Ziętara,Tobias Straub,Regina Feederle,Carolin Daniel,Barbara Adler,Julian König,Stefan Feske,George C Tsokos,Wolfgang Wurst,Henning Urlaub,Michael Sattler,Jan Kisielow,F Gregory Wulczyn,Marcin Łyszkiewicz,Vigo Heissmeyer

International journal of molecular sciences 24: PubMed36675119

2023

First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell Lymphoma Cells via PI3K-AKT and FOXO1-RAG1 Axes.

Applications

Unspecified application

Species

Unspecified reactive species

Min Feng,Kun Yang,Jia Wang,Guilan Li,Han Zhang

Nature communications 13:6954 PubMed36376298

2022

The 3D enhancer network of the developing T cell genome is shaped by SATB1.

Applications

Unspecified application

Species

Unspecified reactive species

Tomas Zelenka,Antonios Klonizakis,Despina Tsoukatou,Dionysios-Alexandros Papamatheakis,Sören Franzenburg,Petros Tzerpos,Ioannis-Rafail Tzonevrakis,George Papadogkonas,Manouela Kapsetaki,Christoforos Nikolaou,Dariusz Plewczynski,Charalampos Spilianakis

Cancer communications (London, England) 41:1116-1136 PubMed34699692

2021

DNA crosslinking and recombination-activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Zhang,Nuo Cheng,Zhihui Li,Ling Bai,Chengli Fang,Yuwen Li,Weina Zhang,Xue Dong,Minghao Jiang,Yang Liang,Sujiang Zhang,Jianqing Mi,Jiang Zhu,Yu Zhang,Sai-Juan Chen,Yajie Zhao,Xiang-Qin Weng,Weiguo Hu,Zhu Chen,Jinyan Huang,Guoyu Meng

The Journal of experimental medicine 218: PubMed34033676

2021

Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activity is required for V(D)J recombination.

Applications

Unspecified application

Species

Unspecified reactive species

Chun-Chin Chen,Bo-Ruei Chen,Yinan Wang,Philip Curman,Helen A Beilinson,Ryan M Brecht,Catherine C Liu,Ryan J Farrell,Jaime de Juan-Sanz,Louis-Marie Charbonnier,Shingo Kajimura,Timothy A Ryan,David G Schatz,Talal A Chatila,Jakob D Wikstrom,Jessica K Tyler,Barry P Sleckman

Nucleic acids research 48:3553-3566 PubMed32086526

2020

Recombination may occur in the absence of transcription in the immunoglobulin heavy chain recombination centre.

Applications

Unspecified application

Species

Unspecified reactive species

Chloé Oudinet,Fatima-Zohra Braikia,Audrey Dauba,Ahmed Amine Khamlichi

Frontiers in immunology 9:2426 PubMed30483245

2018

Misregulation of the Locus in Thymocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Gita Kumari,Tatiana Gerasimova,Hansen Du,Supriyo De,William H Wood,Kevin G Becker,Ranjan Sen

Molecular and cellular biology 38: PubMed29760281

2018

The RAG-2 Inhibitory Domain Gates Accessibility of the V(D)J Recombinase to Chromatin.

Applications

Unspecified application

Species

Unspecified reactive species

Alyssa Ward,Gita Kumari,Ranjan Sen,Stephen Desiderio
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com